Johnson & Johnson Innovation is looking to award up to $100,000 in grants, one year of JLABS residency & mentorship to the individuals or teams who submit the best ideas, technologies, or solutions that are using artificial intelligence to advance healthcare.

Johnson & Johnson Innovation and Janssen Research & Development are looking for entrepreneurs & innovators with the best ideas, technologies, or solutions across all stages (ideation, pre-clinical, clinical, post-approval) that are using artificial intelligence to advance drug discovery & development in any of these areas:

  • Oncology & immuno-oncology
  • Immunology
  • Cardiovascular & metabolism
  • Infectious diseases & vaccines
  • Neuroscience
  • Pulmonary hypertension
  • Rare diseases
  • Pre-clinical safety studies
  • Systems pharmacology
  • Clinical trials
  • Precision medicine
  • Chemo-informatics
  • In silico compound & safety profiling
  • Real world evidence

At Johnson & Johnson Innovation and Janssen Research & Development, the goal is to improve the health and wellness of people around the world. Artificial intelligence (AI) poses unlimited opportunity to make a transformative impact on patients. Whether it be through new drug combinations, improved medical diagnostics, better accuracy in personalized medicine, or many other benefits – AI could save scientists valuable research time and bring new treatments to patients more quickly. 

Rewards and benefits

  • Up to $100,000 USD in grants for multiple winners
  • Residency at an available JLABS location
  • Mentoring & coaching from J&J experts

Deadline to apply is October 27th, 2017
Winners will be announced on December 12th, 2017.

Solutions will be evaluated based on their ability to meet the following criteria:

  • Scientific/Technical Excellence
  • Novelty
  • Feasibility/Practicality
  • Perceived commercialization potential
  • Clarity on milestones and deliverables
  • Quality of Team and Resources
  • Plan for use of funds

Apply now at Johnson & Johnson Innovation.